(Q53410919)
Statements
Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99). (English)
Rolf Fimmers
Roswitha Siener
Su-In Park
Peter Albers
German Association of Urological Oncology Bladder Cancer Group
4 August 2011
60
5
1087-1096